ABIOMED INC — key financial figures for fiscal year 2021 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2021)

$1.0B

Net Income/Loss (FY2021)

$136.5M

Total Assets (FY2021)

$1.7B

Total Equity (FY2021)

$1.5B

Cash Flows from Operating Activities (FY2021)

$285.4M

Source: ABIOMED INC 10-K filing (FY2021). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.